title: Antipsychotic medication prescribing trends in children and adolescents.
abstract: The Food and Drug Administration has approved the use of antipsychotic medications in some children and adolescents with severe emotional and behavioral disorders. However, recent national data show a dramatic rise in off-label and Food and Drug Administration-approved uses of these medications. Of particular note is a twofold to fivefold increase in the use of antipsychotic medications in preschool children, despite little information on their long-term effects. This article describes the trend in pediatric antipsychotic medication use, possible explanations for the increase, implications for children's health, and recommendations for pediatric providers who work with parents of children and adolescents who seek or receive antipsychotic medication treatments.
authors.affiliation: Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. jharri47@jhmi.edu
authors.forename: Joyce Nolan
authors.initials: JN
authors.lastname: Harrison
authors.forename: Fallon
authors.initials: F
authors.lastname: Cluxton-Keller
authors.forename: Deborah
authors.initials: D
authors.lastname: Gross
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002648:Child; D004334:Drug Administration Schedule; D011307:Drug Prescriptions / Q000592:standards / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000451:nursing*; D056687:Off-Label Use; D010818:Practice Patterns, Physicians' / Q000639:trends*
chemical_list: D014150:Antipsychotic Agents